| Biologic Therapy |
1 |
1 |
| CAR-T |
0 |
0.95 |
| Remission |
0 |
0.22 |
| Non-Hodgkin Lymphoma (NHL) |
0 |
0.17 |
| Healthcare and Medical Technology |
0 |
0.15 |
| Biomedical Technology |
0 |
0.11 |
| Tumor |
0 |
0.11 |
| CNS Lymphoma |
0 |
0.1 |
| Diffuse Large B-Cell Lymphoma |
0 |
0.1 |
| Primary CNS Lymphoma |
0 |
0.1 |
| CT Scan |
0 |
0.09 |
| Stem Cell Research and Therapy |
0 |
0.09 |
| B-Cell Lymphoma |
0 |
0.08 |
| Leukemia |
0 |
0.08 |
| Toxicology |
0 |
0.08 |
| Care and Maintenance of Vision |
0 |
0.07 |
| Chemotherapy |
0 |
0.07 |
| Cytokines |
0 |
0.07 |
| Hospital |
0 |
0.07 |
| Lymphoma |
0 |
0.07 |
| Memory |
0 |
0.07 |
| Acute Leukemia |
0 |
0.06 |